Company / Net Income
Omnicell Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$2.1M
FY2025
5-year range
-$20.4M / $61.3M
FY2021-FY2025
Trend
-83.6%
vs FY2024
Sector context
#95 of 164
Health Care
What the data says
At $2M, Omnicell's net income ranks #95 of 164 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$20M in FY2023 to $61M in FY2021.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -44.1%.
Improved from -$20M to $2M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -60.1%
- 5-Year CAGR
- -44.1%
- 10-Year CAGR
- -
Sector benchmark
#95 of 164 in Health CareTop 58% of 164This company $2.1M Sector average $467.5M
▼
-99.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -44.1%, indicating a declining trend.
- In FY2025, net income decreased 83.6% year-over-year.
- Ranks #95 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.1M | -83.6% |
| FY2024 | $12.5M | +161.5% |
| FY2023 | -$20.4M | -163.3% |
| FY2022 | $32.2M | -47.5% |
| FY2021 | $61.3M | +62.6% |
| FY2020 | $37.7M | +23.6% |
| FY2019 | $30.5M | -19.1% |
| FY2018 | $37.7M | +23.6% |
| FY2017 | $30.5M | +0.0% |
| FY2016 | $30.5M | -0.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026